Transaction in Own Shares

RNS Number : 5900Y
Impellam Group plc
22 August 2018
 

22 August 2018

Impellam Group plc

("Impellam" or the "Company")

 

Transaction in Own Shares and Total Voting Rights

 

Further to its announcement on 26 July 2018 regarding a proposed share buy-back programme of up to £12 million over twelve months (the Share Purchase Plan"), the Company announces that it has purchased 32,500 ordinary shares of 1p each ("Ordinary Shares"), at a price of 610 pence per share for cancellation. The Company purchased these Ordinary Shares through Cenkos Securities plc acting as its broker.

 

Date of purchase:

22 August 2018

Number of Ordinary Shares purchased (aggregated volume):

32,500

Price paid per Ordinary Share (pence):

610

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

Following cancellation of the Ordinary Shares purchased on 22 August 2018, the number of Ordinary Shares admitted to trading on AIM will be reduced to 50,217,421. For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, following this cancellation, the Company will have 50,217,421 Ordinary Shares in issue, of which none will be held in treasury. Therefore, the total number of voting rights in the Company will be 50,217,421; this figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Under the Share Purchase Plan, the Company will continue to instruct Cenkos Securities plc to acquire Ordinary Shares for cancellation. The maximum price paid for such Ordinary Shares shall be an amount equal to the higher of (i) 5% above the average of the middle market quotations for the Ordinary Shares for the five business days prior to making any purchase; and (ii) the higher of the price of the last independent trade of and the highest current independent bid for an Ordinary Share on the London Stock Exchange's AIM market. 

Notwithstanding the average daily volume restrictions set out in Article 3(3) (b) of the Commission Delegated Regulation (EU) 2016/1052, the Company may make purchases in excess of these volume restrictions, subject to prevailing market conditions and liquidity.

 

Enquiries:

Impellam Group plc

 

Julia Robertson, Chief Executive Officer                          01582 692658

Alison Wilford, Chief Financial Officer 

 

Cenkos Securities plc (Nomad and Corporate broker)

 

Nicholas Wells / Mark Connelly                                            020 7397 8900

 

Note to Editors:

Impellam is the second largest1 staffing business in the UK and sixth largest2 Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 18 market-leading brands across 168 worldwide locations.

 

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit: www.impellam.com

 

1   By revenue (2016 published numbers)

2   By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our     Managed Service brands manage on behalf of their clients whether acting as a principal or agent. Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSSEWFFEFASELA
UK 100

Latest directors dealings